Figure 4.
Figure 4. Impact of myeloid differentiation on apoptosis susceptibility. (A) Differentiation of P39 cells. Cells were stimulated for the indicated period with ATRA or vitamin D3 in the absence or presence of z-VAD-fmk, followed by immunocytofluorometric detection of the differentiation marker CD11b. (B-C) Differentiation-associated cell death. Cells treated as in panel A were analyzed for any of 3 apoptotic parameters, namely ΔΨm loss (B), phosphatidyl serine (PS) exposure (C), and PI staining (B-C). (D-G) Effect of NF-κB inhibitors on differentiating P39 cells. Cells were cultured with the indicated combinations of ATRA, vitamin D3, BAY11-7082, and/or bortezomib for 24 hours (D-E) or 72 hours (F-G), then labeled with DiOC6(3) plus PI (D,F) or FITC-labeled annexin-V plus PI (E,G), and subjected to flow cytometric analyses. This experiment was repeated 4 times, yielding comparable results. Values are expressed as means ± SD; n = 3.

Impact of myeloid differentiation on apoptosis susceptibility. (A) Differentiation of P39 cells. Cells were stimulated for the indicated period with ATRA or vitamin D3 in the absence or presence of z-VAD-fmk, followed by immunocytofluorometric detection of the differentiation marker CD11b. (B-C) Differentiation-associated cell death. Cells treated as in panel A were analyzed for any of 3 apoptotic parameters, namely ΔΨm loss (B), phosphatidyl serine (PS) exposure (C), and PI staining (B-C). (D-G) Effect of NF-κB inhibitors on differentiating P39 cells. Cells were cultured with the indicated combinations of ATRA, vitamin D3, BAY11-7082, and/or bortezomib for 24 hours (D-E) or 72 hours (F-G), then labeled with DiOC6(3) plus PI (D,F) or FITC-labeled annexin-V plus PI (E,G), and subjected to flow cytometric analyses. This experiment was repeated 4 times, yielding comparable results. Values are expressed as means ± SD; n = 3.

Close Modal

or Create an Account

Close Modal
Close Modal